RBC Keeps Alcon at Outperform Ahead of Q1 Results
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* With UNITY VCS and UNITY CS
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $120.75
NanoDrops Names Daria Lemann-Blumenthal as CEO
AlphaValue/Baader Europe Upgrades Alcon to Add, Lowers PT
Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk
Alcon To Go Ex-Dividend On May 14th, 2025 With 0.28772 USD Dividend Per Share
Bernstein Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $114.94
Alcon | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | Alcon Proposes CHF 0.28 Cash Dividend Ahead Of 2025 AGM And Nomination Of New Tech-Focused Board Member
Alcon Expands Leadership in IOL Innovation With Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter
UBS Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $114.04
UBS Sticks to Their Buy Rating for Alcon (ALC)
Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $108.65
Alcon Price Target Raised to CHF 96 From CHF 92 at Deutsche Bank
Alcon Is Maintained at Overweight by Keybanc
KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $112
Alcon Price Target Raised to $112 From $108 at KeyBanc
KeyBanc Sticks to Its Buy Rating for Alcon (ALC)
Trump's Medical Tariffs Could Significantly Hurt These European Healthcare Firms